Add Company
Join Now

Solute Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Defense

Industry

Estimated Revenue & Valuation

  • Solute's estimated annual revenue is currently $72.2M per year.(i)
  • Solute's estimated revenue per employee is $448,226

Employee Data

  • Solute has 161 Employees.(i)
  • Solute grew their employee count by -15% last year.

Solute's People

NameTitleEmail/Phone
1
C4ISR SR AnalystReveal Email/Phone
2
Senior AnalystReveal Email/Phone
3
Senior Operations SpecialistReveal Email/Phone
4
Contracts AdministrationReveal Email/Phone
5
DevOps EngineerReveal Email/Phone
6
Mid-Level Programs AnalystReveal Email/Phone
7
Software EngineerReveal Email/Phone
8
DevOps EngineerReveal Email/Phone
9
Software EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A5253%N/AN/A
#2
$39.1M12914%N/AN/A
#3
$18.8M645%N/AN/A
#4
$29.6M916%N/AN/A
#5
$11.8M34-21%N/AN/A
#6
$33.3M10813%N/AN/A
#7
$25.6M83-2%N/AN/A
#8
$29M78-7%N/AN/A
#9
$10.1M31-16%N/AN/A
#10
$32M91-2%N/AN/A
Add Company

What Is Solute?

SOLUTE is a Service-Disabled, Veteran-Owned Small Business (SDVOSB) founded in 2002 to solve high-end/complex engineering problems for Government clients who are focused on delivering essential operational capabilities. SOLUTE has a long history of service to DoD customers, with a particularly close relationship with the U.S. Navy and the Space and Naval Warfare Systems Center (SPAWAR). With a proud military heritage and participation in numerous operational, training, and test and evaluation exercises, SOLUTE provides clients with valuable subject matter expertise and the top engineering minds required for cutting-edge research and development.

keywords:N/A

N/A

Total Funding

161

Number of Employees

$72.2M

Revenue (est)

-15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Solute News

2022-04-20 - OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases

OMass's pipeline of small molecule therapeutics includes five programs in rare diseases and immunological conditions that target solute...

2022-04-17 - APP-solute rubbish!

APP-solute rubbish!...

2022-03-22 - The solute carrier SLC15A4 is required for optimal trafficking ...

The solute carrier SLC15A4 is required for optimal trafficking of nucleic acid–sensing TLRs and ligands to endolysosomes · Significance · Abstract.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$46.5M161-3%N/A
#2
$36M1629%N/A
#3
$57.9M1629%N/A
#4
$12.4M16327%N/A
#5
$6M1647%$480M